These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28727277)

  • 21. Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
    Fodor A; Broggi S; Incerti E; Dell'Oca I; Fiorino C; Samanes Gajate AM; Pasetti M; Cattaneo MG; Passoni P; Gianolli L; Calandrino R; Picchio M; Di Muzio N
    Clin Lung Cancer; 2019 Jan; 20(1):e29-e38. PubMed ID: 30253920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution.
    Bece A; Tin MM; Martin D; Lin R; McLean J; McCaughan B
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):355-62. PubMed ID: 25753747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survey of malignant pleural mesothelioma treatment in Japan: Patterns of practice and clinical outcomes in tomotherapy facilities.
    Nakanishi-Imai M; Murai T; Onishi M; Mouri A; Komiyama T; Omura M; Kudo S; Miyamoto A; Hoshino M; Ogawa S; Ohashi S; Koizumi M; Omagari J; Mayahara H; Karasawa K; Okumura T; Shibamoto Y
    J Radiat Res; 2022 Mar; 63(2):281-289. PubMed ID: 35138408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Helical tomotherapy in the treatment of malignant pleural mesothelioma: The impact of low doses on pulmonary and oesophageal toxicity].
    Helou J; Clément-Colmou K; Sylvestre A; Campion L; Amessis M; Zefkili S; Raphael J; Bonnette P; Le Pimpec Barthes F; Périgaud C; Mahé MA; Giraud P
    Cancer Radiother; 2013 Dec; 17(8):755-62. PubMed ID: 24269017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation.
    Mattson K; Holsti LR; Tammilehto L; Maasilta P; Pyrhönen S; Mäntylä M; Kajanti M; Salminen US; Rautonen J; Kivisaari L
    Int J Radiat Oncol Biol Phys; 1992; 24(4):643-50. PubMed ID: 1429086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.
    Minatel E; Trovo M; Polesel J; Rumeileh IA; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Drigo A; Dassie A; Pagan V; Trovo MG
    J Thorac Oncol; 2012 Dec; 7(12):1862-1866. PubMed ID: 23154558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation therapy for malignant pleural mesothelioma.
    Rosenzweig KE; Giraud P
    Cancer Radiother; 2017 Feb; 21(1):73-76. PubMed ID: 28237609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.
    Minatel E; Trovo M; Polesel J; Baresic T; Bearz A; Franchin G; Gobitti C; Rumeileh IA; Drigo A; Fontana P; Pagan V; Trovo MG
    Lung Cancer; 2014 Jan; 83(1):78-82. PubMed ID: 24216141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
    Rice DC; Smythe WR; Liao Z; Guerrero T; Chang JY; McAleer MF; Jeter MD; Correa A; Vaporciyan AA; Liu HH; Komaki R; Forster KM; Stevens CW
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):350-7. PubMed ID: 17467922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
    Miles EF; Larrier NA; Kelsey CR; Hubbs JL; Ma J; Yoo S; Marks LB
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1143-50. PubMed ID: 18262369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Rosenzweig KE
    Semin Thorac Cardiovasc Surg; 2013; 25(3):245-50. PubMed ID: 24331147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy.
    Gupta V; Krug LM; Laser B; Hudka K; Flores R; Rusch VW; Rosenzweig KE
    J Thorac Oncol; 2009 Jun; 4(6):746-50. PubMed ID: 19404212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques.
    Hill-Kayser CE; Avery S; Mesina CF; James P; Friedberg JS; Cengel K; Lin LL; Hahn SM; Rengan R
    J Thorac Oncol; 2009 Nov; 4(11):1431-7. PubMed ID: 19745767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.
    Shaaban SG; Verma V; Choi JI; Shabason J; Sharma S; Glass E; Grover S; Badiyan SN; Simone CB
    Clin Lung Cancer; 2018 Sep; 19(5):e685-e692. PubMed ID: 29803576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant Pleural Mesothelioma: A Multi-Disciplinary Approach.
    Mansha MA; Ali N; Ali S; Azam N; Khan AMH
    Gulf J Oncolog; 2019 May; 1(30):76-80. PubMed ID: 31242986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of palliative radiotherapy in malignant mesothelioma.
    Bissett D; Macbeth FR; Cram I
    Clin Oncol (R Coll Radiol); 1991 Nov; 3(6):315-7. PubMed ID: 1720658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy.
    Kimura T; Doi Y; Nakashima T; Imano N; Katsuta T; Takahashi S; Kenjo M; Ozawa S; Murakami Y; Nagata Y
    J Radiat Res; 2015 Mar; 56(2):315-24. PubMed ID: 25599996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
    Leitzen C; Wilhelm-Buchstab T; Stumpf S; Heimann M; Koch D; Schmeel C; Simon B; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H; Müdder T
    Strahlenther Onkol; 2019 Jul; 195(7):668-676. PubMed ID: 30915490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locoregional control and toxicity after pleurectomy/decortication and intensity-modulated pleural radiation therapy in patients with malignant pleural mesothelioma.
    Arrieta O; Lozano-Ruiz F; Blake-Cerda M; Catalán R; Lara-Mejía L; Salinas MÁ; Maldonado-Magos F; Corona-Cruz JF
    Thorac Cancer; 2020 Dec; 11(12):3448-3455. PubMed ID: 33030313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.